419 related articles for article (PubMed ID: 22999048)
1. Analysis of the treatment of congenital vascular malformations using a multidisciplinary approach.
Lidsky ME; Markovic JN; Miller MJ; Shortell CK
J Vasc Surg; 2012 Nov; 56(5):1355-62; discussion 1362. PubMed ID: 22999048
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
Markovic JN; Nag U; Shortell CK
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
[TBL] [Abstract][Full Text] [Related]
3. The role of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis and management of patients with vascular malformations.
Lidsky ME; Spritzer CE; Shortell CK
J Vasc Surg; 2012 Sep; 56(3):757-64.e1. PubMed ID: 22840741
[TBL] [Abstract][Full Text] [Related]
4. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
Odeyinde SO; Kangesu L; Badran M
J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
[TBL] [Abstract][Full Text] [Related]
5. A 6-year experience treating vascular malformations with foam sclerotherapy.
Markovic JN; Kim CY; Lidsky ME; Shortell CK
Perspect Vasc Surg Endovasc Ther; 2012 Jun; 24(2):70-9. PubMed ID: 22918935
[TBL] [Abstract][Full Text] [Related]
6. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
[TBL] [Abstract][Full Text] [Related]
7. Incidence of major complication following embolo-sclerotherapy for upper and lower extremity vascular malformations.
Lim CS; Evans N; Kaur I; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Brookes J
Vascular; 2021 Feb; 29(1):69-77. PubMed ID: 32605532
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary treatment of extremity arteriovenous malformations.
Markovic JN; Shortell CE
J Vasc Surg Venous Lymphat Disord; 2015 Apr; 3(2):209-18. PubMed ID: 26993843
[TBL] [Abstract][Full Text] [Related]
9. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K
Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546
[TBL] [Abstract][Full Text] [Related]
10. Staged endovascular and surgical treatment of slow-flow vulvar venous malformations.
Nassiri N; O TM; Rosen RJ; Moritz J; Waner M
Am J Obstet Gynecol; 2013 May; 208(5):366.e1-6. PubMed ID: 23395642
[TBL] [Abstract][Full Text] [Related]
11. Management of severe craniofacial vascular malformation operated under bypass: evolution from a "no-flow" to a "low-flow".
Lessard L; Izadpanah A; Dobell AR; Williams BH
J Craniofac Surg; 2013 Jan; 24(1):120-5. PubMed ID: 23348267
[TBL] [Abstract][Full Text] [Related]
12. Preoperative sclerotherapy of facial venous malformations: impact on surgical parameters and long-term follow-up.
James CA; Braswell LE; Wright LB; Roberson PK; Moore MB; Waner M; Buckmiller LM
J Vasc Interv Radiol; 2011 Jul; 22(7):953-60. PubMed ID: 21550819
[TBL] [Abstract][Full Text] [Related]
13. Treatment of facial vascular malformations with embolisation and surgical resection.
Pompa V; Brauner E; Bresadola L; Di Carlo S; Valentini V; Pompa G
Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):407-13. PubMed ID: 22530359
[TBL] [Abstract][Full Text] [Related]
14. Incidence of soft tissue injury and neuropathy after embolo/sclerotherapy for congenital vascular malformation.
Lee KB; Kim DI; Oh SK; Do YS; Kim KH; Kim YW
J Vasc Surg; 2008 Nov; 48(5):1286-91. PubMed ID: 18829241
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous management of peripheral vascular malformations: a single center experience.
Türkbey B; Peynircioğlu B; Arat A; Canyiğit M; Ozer C; Vargel I; Balkanci F; Cil B
Diagn Interv Radiol; 2011 Dec; 17(4):363-7. PubMed ID: 21204044
[TBL] [Abstract][Full Text] [Related]
16. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations.
Khandpur S; Sharma VK
Dermatol Surg; 2010 Mar; 36(3):340-6. PubMed ID: 20100267
[TBL] [Abstract][Full Text] [Related]
17. Management of arteriovenous malformations: a multidisciplinary approach.
Lee BB; Do YS; Yakes W; Kim DI; Mattassi R; Hyon WS
J Vasc Surg; 2004 Mar; 39(3):590-600. PubMed ID: 14981454
[TBL] [Abstract][Full Text] [Related]
18. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
[TBL] [Abstract][Full Text] [Related]
19. The results of surgical treatment for patients with venous malformations.
Roh YN; Do YS; Park KB; Park HS; Kim YW; Lee BB; Pyon JK; Lim SY; Mun GH; Kim DI
Ann Vasc Surg; 2012 Jul; 26(5):665-73. PubMed ID: 22664281
[TBL] [Abstract][Full Text] [Related]
20. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation.
Lee BB; Kim DI; Huh S; Kim HH; Choo IW; Byun HS; Do YS
J Vasc Surg; 2001 Apr; 33(4):764-72. PubMed ID: 11296330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
